Signals
Migraine Still Refuses a Simple Blood Test
A large Danish registry study challenges the idea that plasma CGRP can serve as a diagnostic biomarker for migraine. The pathway matters. The blood test may not.
Corxel’s oral GLP-1 trial adds momentum. The real question is who these drugs will reach
Eight Patients Cannot Solve Alzheimer’s. They Can Tell Us What the Next Trial Must Prove.
The ICU Has a New Signal. It Is Not a Verdict.
West Nile Is Back. Blood Safety Cannot Lag.
Deep learning uncovers a new ECG biomarker for sudden cardiac death
Half of CKM patients go untreated and most fail control
The Trial Has Started. Now the System Has to Find the Children.
Sleep is now cardiovascular prevention. Health systems still treat it like lifestyle advice
The GLP-1 boom still needs exercise policy
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.